Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Primate-specific ZNF808 is essential for pancreatic development in humans

View ORCID ProfileElisa De Franco, View ORCID ProfileNick D L Owens, View ORCID ProfileHossam Montaser, View ORCID ProfileMatthew N Wakeling, View ORCID ProfileJonna Saarimäki-Vire, View ORCID ProfileHazem Ibrahim, Athina Triantou, View ORCID ProfileDiego Balboa, View ORCID ProfileRichard C Caswell, View ORCID ProfileMatthew B Johnson, View ORCID ProfileSian Ellard, View ORCID ProfileCaroline F Wright, Pancreatic Agenesis Gene Discovery Consortium, View ORCID ProfileSarah E Flanagan, View ORCID ProfileTimo Otonkoski, View ORCID ProfileAndrew T Hattersley, View ORCID ProfileMichael Imbeault
doi: https://doi.org/10.1101/2021.08.23.21262262
Elisa De Franco
1Institute of Biomedical and Clinical Sciences, University of Exeter College of Medicine and Health, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elisa De Franco
Nick D L Owens
1Institute of Biomedical and Clinical Sciences, University of Exeter College of Medicine and Health, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nick D L Owens
Hossam Montaser
2Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hossam Montaser
Matthew N Wakeling
1Institute of Biomedical and Clinical Sciences, University of Exeter College of Medicine and Health, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew N Wakeling
Jonna Saarimäki-Vire
2Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonna Saarimäki-Vire
Hazem Ibrahim
2Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hazem Ibrahim
Athina Triantou
3Department of Genetics. University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego Balboa
4Regulatory Genomics and Diabetes, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diego Balboa
Richard C Caswell
1Institute of Biomedical and Clinical Sciences, University of Exeter College of Medicine and Health, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard C Caswell
Matthew B Johnson
1Institute of Biomedical and Clinical Sciences, University of Exeter College of Medicine and Health, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew B Johnson
Sian Ellard
5Genomics Laboratory, Royal Devon and Exeter Foundation Trust, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sian Ellard
Caroline F Wright
1Institute of Biomedical and Clinical Sciences, University of Exeter College of Medicine and Health, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caroline F Wright
Sarah E Flanagan
1Institute of Biomedical and Clinical Sciences, University of Exeter College of Medicine and Health, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah E Flanagan
Timo Otonkoski
2Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
6Children’s Hospital, Helsinki University Hospital, and University of Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timo Otonkoski
  • For correspondence: timo.otonkoski@helsinki.fi A.T.Hattersley@exeter.ac.uk mi339@cam.ac.uk
Andrew T Hattersley
1Institute of Biomedical and Clinical Sciences, University of Exeter College of Medicine and Health, Exeter, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew T Hattersley
  • For correspondence: timo.otonkoski@helsinki.fi A.T.Hattersley@exeter.ac.uk mi339@cam.ac.uk
Michael Imbeault
3Department of Genetics. University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Imbeault
  • For correspondence: timo.otonkoski@helsinki.fi A.T.Hattersley@exeter.ac.uk mi339@cam.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Identifying genes linked to extreme phenotypes in humans has the potential to highlight new biological processes fundamental for human development. Here we report the identification of homozygous loss of function variants in the primate-specific gene ZNF808 as a cause of pancreatic agenesis. ZNF808 is a member of the KRAB zinc finger protein (KZFPs) family, a large and rapidly evolving group of epigenetic silencers that target transposable elements. We show that loss of ZNF808 in vitro results in aberrant activation of many transposable elements it normally represses during early pancreas development. This results in inappropriate specification of cell fate with induction of genes associated with liver endoderm and a loss of pancreatic identity. We show that ZNF808 and its transposable element targets play a critical role in cell fate specification during human pancreatic development. This is the first report of loss of a primate-specific gene causing a congenital developmental disease and highlights the essential role of ZNF808 for pancreatic development in humans.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

EDF is a Diabetes UK RD Lawrence Fellow (19/005971) and has been the recipient of an EASD Rising Star fellowship during this study. ATH and SE were the recipients of a Wellcome Trust Senior Investigator award (grant WT098395/Z/12/Z) during this study, and ATH is employed as a core member of staff within the National Institute for Health Research funded Exeter Clinical Research Facility and is an NIHR Emeritus Senior Investigator. SEF and MI have Sir Henry Dale Fellowships jointly funded by the Wellcome Trust and the Royal Society (grant 105636/Z/14/Z and 206688/Z/17/Z, respectively). NO has a lectureship funded by a Research England Expanding Excellence in England (E3) award. Most of the experimental studies were funded by the Academy of Finland Center of Excellence MetaStem (grant 312437). The Novo Nordisk Foundation and the Sigrid Juselius Foundation. HM is a member of the Doctoral Program in Integrative Life Science at University of Helsinki. AT Doctoral studies were funded by the Foundation for Education and European Culture (IPEP) in Greece and by the Cambridge Trust. DB received funding from a European Molecular Biology Organization long term fellowship (ALTF 295/2019).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethical approval for the patient DNA analysis in this study was part of the Genetic Beta Cell Research Bank based in Exeter this was approved by Wales Research Ethics Committee 5 on 20/05/13 (REC ref 12/WA/0225) and renewed on 26/10/2017 (REC ref 17/WA/0327)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data will be made available on publication in a peer reviewed publication. All disease-causing variants identified by next generation sequencing will be uploaded onto the DECIPHER database (https://decipher.sanger.ac.uk/). All variants identified through genome sequencing will be submitted as a .vcf file with allele frequencies to the EMBL-EBI European Genome-Phenome Archive (EGA) (https://www.ebi.ac.uk/ega/home).

All epigenomic and transcriptomic data from in vitro pancreatic differentiation will be deposited in NCBI Gene Expression Omnibus (GEO, https://www.ncbi.nlm.nih.gov/geo/).

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE78099

https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3259/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Primate-specific ZNF808 is essential for pancreatic development in humans
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Primate-specific ZNF808 is essential for pancreatic development in humans
Elisa De Franco, Nick D L Owens, Hossam Montaser, Matthew N Wakeling, Jonna Saarimäki-Vire, Hazem Ibrahim, Athina Triantou, Diego Balboa, Richard C Caswell, Matthew B Johnson, Sian Ellard, Caroline F Wright, Pancreatic Agenesis Gene Discovery Consortium, Sarah E Flanagan, Timo Otonkoski, Andrew T Hattersley, Michael Imbeault
medRxiv 2021.08.23.21262262; doi: https://doi.org/10.1101/2021.08.23.21262262
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Primate-specific ZNF808 is essential for pancreatic development in humans
Elisa De Franco, Nick D L Owens, Hossam Montaser, Matthew N Wakeling, Jonna Saarimäki-Vire, Hazem Ibrahim, Athina Triantou, Diego Balboa, Richard C Caswell, Matthew B Johnson, Sian Ellard, Caroline F Wright, Pancreatic Agenesis Gene Discovery Consortium, Sarah E Flanagan, Timo Otonkoski, Andrew T Hattersley, Michael Imbeault
medRxiv 2021.08.23.21262262; doi: https://doi.org/10.1101/2021.08.23.21262262

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (501)
  • Anesthesia (110)
  • Cardiovascular Medicine (1233)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10012)
  • Forensic Medicine (5)
  • Gastroenterology (498)
  • Genetic and Genomic Medicine (2448)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1636)
  • Health Policy (751)
  • Health Systems and Quality Improvement (635)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11860)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2277)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (452)
  • Occupational and Environmental Health (534)
  • Oncology (1245)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (155)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4828)
  • Radiology and Imaging (834)
  • Rehabilitation Medicine and Physical Therapy (490)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (226)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)